1. Home
  2. MAPS vs ACET Comparison

MAPS vs ACET Comparison

Compare MAPS & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WM Technology Inc.

MAPS

WM Technology Inc.

HOLD

Current Price

$0.66

Market Cap

70.7M

Sector

Technology

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$6.76

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAPS
ACET
Founded
2008
1947
Country
United States
United States
Employees
449
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.7M
69.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
MAPS
ACET
Price
$0.66
$6.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$2.61
$48.33
AVG Volume (30 Days)
685.1K
92.6K
Earning Date
03-12-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.17
N/A
P/E Ratio
$9.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.45
52 Week High
$1.36
$9.05

Technical Indicators

Market Signals
Indicator
MAPS
ACET
Relative Strength Index (RSI) 47.80 47.44
Support Level $0.65 $6.54
Resistance Level $0.88 $8.34
Average True Range (ATR) 0.04 0.38
MACD -0.00 -0.07
Stochastic Oscillator 36.79 45.24

Price Performance

Historical Comparison
MAPS
ACET

About MAPS WM Technology Inc.

WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: